US45337C1027
US45337C1027
Incyte Corporation
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 5.141.242.000 | 4.241.217.000 | 21.2% |
| Cost of Revenue | 372.100.000 | 312.100.000 | 19.2% |
| Gross Profit | 4.769.142.000 | 3.929.117.000 | 21.4% |
| 3.426.352.000 | 3.827.823.000 | 10.5% | |
| Operating Income | 1.342.790.000 | 101.294.000 | 1225.6% |
| Pretax Income | 1.664.451.000 | 316.630.000 | 425.7% |
| Net Income Common Stockholders | 1.286.650.000 | 32.615.000 | 3845.0% |
| -- | -- | -- | |
| -- | -- | -- |